Voyageur Pharmaceuticals Ltd V.VM

VM research paper. Very thorough

[oldtrouf]

They had a fair value price on VM of .39 BEFORE any Health Canada approval.  The recent approval may up this s bit  ; ).    Great times ahead.  Remids me a lot of T.NEXT.   A company that controls their raw material source is in a very good place.  

https://media.stockhouse.com/media/companies/v-vm/eqp/FR-Analyst-Initiates-Buy-on-Voyageur-Jan07-2020.pdf#eqp062020-irpres

[lscfa]

That valuation was based solely on the resource project. With the Health Canada approval the co. can source the material from a 3rd party and begin sales in Canada now to start generating cash flow.     "We are valuing VM based on the current resource estimate at its Frances Creek barite project."  

[CLSHboss]

This post has been removed in accordance with Community Policy

[lscfa]

The co. is outsourcing the manufacture of the product. Only thing left to do is market it to hospitals and imaging centers.    "The JV will initially target Canada, and is currently awaiting approval on its first five products from Health Canada. Primary targets will be diagnostic imaging clinics and hospitals, and products will be sold to wholesale distributors." 

[lscfa]

"In November 2018, the company formed a 50/50 net revenue sharing JV (revenue less regulatory, marketing and sales costs) with Chief Medical Supplies Ltd. (“CMS”), named ImagingX Pharmaceuticals. CMS, headquartered in Calgary, Alberta, is a pharmaceutical manufacturing and distribution company, and primarily offers hemodialysis products to pharmacies and hospitals across Canada."

[lscfa]

Assume Canada is 1/10 the size..... "The contrast media agent market in the U.S. is estimated to have been US$2.1 billion in 2017, with over 60% of the market accounted by iodine, and under 5% by barium based agents." 

[WarrantOfficer]

This JV you made mention of has been dissolved: CALGARY, Alberta, March 20, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (the “Company” or “Voyageur”) is pleased to announce the dissolution of the current joint venture with Chief Medical Supplies (“Chief”). Voyageur and Chief have worked together to create a new working relationship that is more beneficial to both parties

[lscfa]

Even better. If China is currently the only source to get the barite then maybe a Chinese manufacturer for the end product makes economical sense. "The first barite shipment, from a Chinese supplier, considered to be the only entity worldwide which is producing FDA / Health Canada approved natural pharmaceutical grade barite, was delivered to the JV in February 2019."  

[WarrantOfficer]

Please read:  Alberta Veterinarian Laboratories Ltd. V.VM | November 30, 2020 (TheNewswire) Calgary, Alberta - TheNewswire - November 30, 2020 - Voyageur Pharmaceuticals Ltd. ( TSXV : VM ) USA ( OTC : VYYRF) (the "Company"